Jennifer Lawrence was casted to play 32-year-old Elizabeth Holmes in an upcoming film about the rise and fall of her Palo Alto, Calif.-based blood testing startup Theranos.
The story has no shortage of drama — Ms. Holmes is the founder and CEO of a company that was once valued at $9 billion and promised to upend the lab diagnostics industry. However, a pair of investigative reports in The Wall Street Journal launched nearly eight months of continuous bad news for the fallen startup.
The FDA prohibited Theranos from using Edison for all but one test, and it faced a federal inspection and a criminal investigation. CMS threatened to ban Ms. Holmes from operating labs for two years, as well as to revoke the lab's license and impose fines. The startup lost a $350 million deal with Safeway, reduced its board by more than half and recently lost its president and COO, Sunny Balwani. It then recalled tens of thousands of lab results. Most recently the company's net worth was revised to $800 million by Forbes.
The Big Short director Adam McKay is working on the film, according to Deadline, which first reported the news. Gary Sanchez Productions and Kevin Messick plan to approach buyers next week for the film, according to the report.
More articles on leadership and management:
Premise Health expands with new West Coast headquarters: 4 things to know
Georgia Hospital Health Services partners with Jackson Executives for interim C-level leadership support
Musical about Martin Shkreli to open this summer